Shashikant Kulkarni
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
Present Title & Affiliation
Primary Appointment
Deputy Division Head, Professor, Department of Pathology and Laboratory Medicine, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Vice Chairman and Professor of Molecular Pathology and Cytogenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2021 | Quantic School of Business and Technology, Washington, District of Columbia, US, Executive MBA |
| 1997 | All India Institute of Medical Sciences, New Delhi, IN, Medical Genetics, Ph.D |
| 1992 | Sawai Man Singh Medical College, Jaipur, IN, Human Anatomy, M.S. (Medicine) |
| 1988 | Government College, Kota, IN, Biology and Life Sciences, B.Sc |
Postgraduate Training
| 2012-2014 | Clinical Fellow, Clinical Molecular Genetics, Washington University School of Medicine, St. Louis, Missouri |
| 2004-2006 | Clinical Fellow, Clinical Cytogenetics, Harvard Medical School, Boston, Massachusetts |
| 2004-2006 | Research Fellow, Developmental Genome Anatomy Project, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts |
| 2000-2004 | Research Associate, Hematology, Washington University School of Medicine, St. Louis, Missouri |
| 1997-2000 | Clinical Fellow, Clinical Cancer Genomics and Precision Medicine, Hammersmith Hospital, Imperial College, London |
Board Certifications
| 2007 | Fellow of American College of Medical Genetics |
| 2007 | New York State Department of Health CQ |
Experience & Service
Academic Appointments
Professor, Adjunct, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 2022 - 2024
Vice Chairman, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 2016 - 2022
Professor, Department of Pathology & Immunology, Pediatrics, and Genetics, Washington University School of Medicine, St. Louis, Missouri, 2016 - 2016
Chief Scientific Officer, Senior Vice President, Department of Baylor Genetics, Baylor College of Medicine, Miraca Holdings (Japan), Houston, Texas, 2016 - 2022
Professor, Tenured, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, 2016 - 2022
Associate Professor, Department of Pathology and Immunology, Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, Missouri, 2011 - 2015
Associate Professor, Department of Pediatrics, Genetics, and Genomic Medicine, Washington University School of Medicine, St. Louis, Missouri, 2011 - 2015
Assistant Professor, Department of Pathology and Immunology, Laboratory and Genomic Medicine, Washington University School of Medicine, St. Louis, Missouri, 2007 - 2010
Assistant Professor, Department of Pediatrics, Genetics, and Genomic Medicine, Washington University School of Medicine, St. Louis, Missouri, 2006 - 2010
Lecturer, Department of Medical Genetics and Human Cytogenetics, Washington University School of Medicine, St. Louis, Missouri, 2003 - 2003
Senior Demonstrator, Department of Anatomy, All India Institute of Medical Sciences, New Delhi, 1994 - 1997
Administrative Appointments/Responsibilities
President & Chief Scientific Officer, Department of Operations, NeoGenomics Laboratories, Fort Myers, Florida, 2022 - 2023
Committee Member, Department of Continuing Professional Development (CPD) Committee/ Continuing Medical Education (CME) Committee, Baylor College of Medicine, Houston, Texas, 2020 - Present
Committee Member, Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, 2018 - Present
Council Member, Department of Precision Medicine Advancement Council (PMAC), Baylor College of Medicine, Houston, Texas, 2017 - Present
Board Member, Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, 2016 - Present
Director, Department of Cytogenomics and Molecular Pathology, Washington University School of Medicine, St. Louis, Missouri, 2006 - 2016
Program Director, Department of Medical Genetics and Genomics, Washington University School of Medicine, St. Louis, Missouri, 2006 - 2016
Director, Department of Clinical Genomics Research Unit, Washington University School of Medicine, St. Louis, Missouri, 2006 - 2016
Director, Department of Cytogenomics and Molecular Pathology, Washington University School of Medicine, St. Louis, Missouri
Institutional Committee Activities
Committee member, Breast Cancer Leadership Committee
Representative from the clinical departments, Executive Committee of the Faculty Council (ECFC)
Committee member, Molecular Pathology Curriculum Subcommittee
Committee member, Educational Committee
Honors & Awards
| Promotion of Science Visiting Fellowship Award, Indo-French Society Department of Immunogenetics, Pasteur Institute, Paris, France | |
| Excellence In Partnership Award, Centers for Disease Control and Prevention, the Agency for Toxic Substances and Disease Registry of the United States Department of Health and Human Services | |
| Recognition of Outstanding Leadership and Service, Clinical and Laboratory Standards Institute |
Selected Publications
Peer-Reviewed Articles
- Huselton, E, Rettig, MP, Fletcher, TR, Ritchey, JK, Gehrs, L, McFarland, K, Christ, S, Eades, W, Trinkaus, K, Romee, R, Kulkarni, S, Ghobadi, A, Abboud, CN, Cashen, A, Stockerl-Goldstein, K, Uy, GL, Vij, R, Westervelt, P, DiPersio, JF, Schroeder, MA. A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromes. Leukemia and Lymphoma 62(6):1441-1449, 2021. PMID: 33467957.
- Kulkarni S. Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia. N Engl J Med 368(22):2059-2074, 2013. PMID: 23634996.
- Baxter, EJ, Kulkarni, S, Vizmanos, JL, Jaju, R, Martinelli, G, Testoni, N, Hughes, G, Calasanz, MJ, Lahortiga, I, Pocock, CF, Dang, R, Fidler, C, Wainscoat, JS, Boultwood, J, Cross, NCP. Novel translocations that disrupt the platelet-derived growth factor receptor ß (PDGFR ß) gene in BCR-ABL negative chronic myeloproliferative disorders. British Journal of Hematology 120(None):251-256, 2003. PMID: 12542482.
Other Articles
- Wigby, KM, Brockman, D, Costain, G, Hale, C, Taylor, SL, Belmont, J, Bick, DP, Dimmock, D, Fernbach, S, Greally, JM, Jobanputra, V, Kulkarni, S, Spiteri, E, Taft, RJ Evidence review and considerations for use of first line genome sequencing to diagnose rare genetic disorders. npj Genomic Medicine 9(1), 2024. PMID: 38409289.
- Wigby KM, Brockman D, Costain G, Hale C, Taylor SL, Belmont J, Bick D, Dimmock D, Fernback S, Greally J, Jobanputra V, Kulkarni S, Spiteri E, Taft RJ Evidence review and considerations for use of first line genome sequencing to diagnose rare genetic disorders. NPJ Genom Med 9(1):15, 2024. PMID: 38409289.
- Austin-Tse, C, Jobanputra, V, Perry, DL, Bick, DP, Taft, RJ, Venner, E, Gibbs, RA, Young, T, Barnett, S, Belmont, J, Boczek, N, Chowdhury, S, Ellsworth, KA, Guha, S, Kulkarni, S, Marcou, C, Meng, L, Murdock, DR, Rehman, AU, Spiteri, E, Thomas-Wilson, A, Kearney, H, Rehm, HL Best practices for the interpretation and reporting of clinical whole genome sequencing. npj Genomic Medicine 7(1), 2022. PMID: 35395838.
- Horak P, Griffith M, Danos AM, Pitel BA, Madhavan S, Liu X, Chow C, Williams H, Carmody L, Barrow-Liang L, Rieke D, Kreutzfeldt S, Stenzinger A, Tamborero D, Benary M, Rajagopal PS, Ida CM, Lesmana H, Satgunaseelan L, Merker JD, Tolstorukov MY, Campregher PV, Warner JL, Rao S, Natesan M, Shen H, Venstrom J, Roy S, Tao K, Kanagal-Shamanna R, Xu X, Ritter DI, Pagel K, Krysiak K, Dubuc A, Akkari YM, Li XS, Lee J, King I, Raca G, Wagner AH, Li MM, Plon SE, Kulkarni S, Griffith OL, Chakravarty D, Sonkin D Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC) and Variant Interpretation for Cancer Consortium (VICC). Genet Med 24(5):986-998, 2022. PMID: 35101336.
- Austin-Tse CA, Jobanputra V, Perry DL, Bick D, Taft RJ, Venner E, Gibbs RA, Young T, Barnett S, Belmont JW, Boczek N, Chowdhury S, Ellsworth KA, Guha S, Kulkarni S, Marcou C, Meng L, Murdock DR, Rehman AU, Spiteri E, Thomas-Wilson A, Kearney HM, Rehm HL Medical Genome Initiative: Best practices for the interpretation and reporting of clinical whole genome sequencing. Journal Genom Med 7(1):27, 2022. PMID: 35395838.
- Hayeems RZ, Dimmock D, Bick D, Belmont JW, Green RC, Lanpher B, Jobanputra V, Mendoza R, Kulkarni S, Grove ME, Taylor SL, Ashley E Clinical utility of genomic sequencing: a measurement toolkit. NPJ Genom Med 5(1):56, 2020. PMID: 33319814.
- Marshall CR, Bick D, Belmont JW, Taylor SL, Ashley E, Dimmock D, Jobanputra V, Kearney HM, Kulkarni S, Rehm H The Medical Genome Initiative: moving whole-genome sequencing for rare disease diagnosis to the clinic. Genome Med 12(1):48, 2020. PMID: None.
- Marshall CR, Chowdhury S, Taft RJ, Lebo MS, Buchan JG, Harrison SM, Rowsey R, Klee EW, Liu P, Worthey EA, Jobanputra V, Dimmock D, Kearney HM, Bick D, Kulkarni S, Taylor SL, Belmont JW, Stavropoulos DJ, Lennon NJ Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease. NPJ Genom Med 5(47):None, 2020. PMID: 33110627.
- Evenson M, Cai C, Hucthagowder V, McNulty S, Neidich J, Kulkarni S, Dahiya S Utility of copy number variants in the classification of intracranial ependymoma. Cancer Genet 240(None):66-72, 2019. PMID: 31794935.
- Ritter DI, Rao S, Kulkarni S, Madhavan S, Offit K, Plon SE A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen). Cold Spring Harb Mol Case Stud 5(5):a004739, 2019. PMID: None.
- Zhang J, Li J, Saucier JB, Feng Y, Jiang Y, Sinson J, McCombs AK, Schmitt ES, Peacock S, Chen S, Dai H, Ge X, Wang G, Shaw CA, Mei H, Breman A, Xia F, Yang Y, Purgason A, Pourpak A, Chen Z, Wang X, Wang Y, Kulkarni S, Choy KW, Wapner RJ, Van den Veyver IB, Beaudet A, Parmar S, Wong LJ, Eng CM Publisher Correction: Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA. Nat Med 25(4):701-702, 2019. PMID: 30787481.
- Zhang J, Li J, Saucier JB, Feng Y, Jiang Y, Sinson J, McCombs AK, Schmitt ES, Peacock S, Chen S, Dai H, Ge X, Wang G, Shaw CA, Mei H, Breman A, Xia F, Yang Y, Purgason A, Pourpak A, Chen Z, Wang X, Wang Y, Kulkani S, Choy KW, Wapner RJ, Van den Veyver IB, Beaudet A, Parmar S, Wong LJ, Eng CM Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA. Nat Med 25(3):439-447, 2019. PMID: 30692697.
- Rohanizadegan M, Kulkarni S Transformational role of liquid biopsy in diagnosis and treatment of cancer. Cancer Genet None(None):None, 2018. PMID: 30553466.
- Danos AM, Ritter DI, Wagner AH, Krysiak K, Sonkin D, Micheel C, McCoy M, Rao S, Raca G, Boca SM, Roy A, Barnell EK, McMichael JF, Kiwala S, Coffman AC, Kujan L, Kulkarni S, Griffith M, Madhavan S, Griffith OL Clinical Genome Resource Somatic Working Group and Clinical Interpretation of Variants in Cancer team members. Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community-driven standards. Hum Mutat 39(11):1721-1732, 2018. PMID: 30311370.
- Walsh MF, Ritter DI, Kesserwan C, Sonkin D, Chakravarty D, Chao E, Ghosh R, Kemel Y, Wu G, Lee K, Kulkarni S, Hedges D, Mandelker D, Ceyhan-Birsoy O, Luo M, Drazer M, Zhang L, Offit K, Plon SE Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes. Hum Mutat 39(11):1542-1552, 2018. PMID: 30311369.
- Huang KL, Mashl RJ, Wu Y, Ritter DI, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA, Oak N, Scott AD, Krassowski M, Cherniack AD, Houlahan KE, Jayasinghe R, Wang LB, Zhou DC, Liu D, Cao S, Kim YW, Koire A, McMichael JF, Hucthagowder V, Kim TB, Hahn A, Wang C, McLellan MD, Al-Mulla F, Johnson KJ, Lichtarge O, Boutros PC, Raphael B, Lazar AJ, Zhang W, Wendl MC, Govindan R, Jain S, Wheeler D, Kulkarni S, Dipersio JF, Reimand J, Meric-Bernstam F, Chen K, Shmulevich I, Plon SE, Chen F, Ding L Pathogenic Germline Variants in 10,389 Adult Cancers. Cell 173(None):1-16, 2018. PMID: None.
- Rosenbaum JN, Bloom R, Forys JT, Hiken J, Armstrong JR, Branson J, McNulty S, Velu PD, Pepin K, Abel H, Cottrell CE, Pfeifer JD, Kulkarni S, Govindan R, Konnick EQ, Lockwood CM, Duncavage EJ Genomic heterogeneity of ALK fusion breakpoints innon-small-cell lung cancer. None None(None):None, 2018. PMID: 29327716.
- Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN Author's Reply. J Mol Diagn 20(1):125-126, 2018. PMID: 29249244.
- Madhavan S, Ritter D, Micheel C, Rao S, Roy A, Sonkin D, Mccoy M, Griffith M, Griffith OL, Mcgarvey P, Kulkarni S ClinGen Cancer Somatic Working Group - standardizing and democratizing access to cancer molecular diagnostic data to drive translational research. Pac Symp Biocomput 23(None):247-258, 2018. PMID: 29218886.
- Khang J, Griffith M, Miller CA, Griffith OL, Spencer DH, Walker JR, Magrini V, McGrath SD, Ly A, Helton NM, Trissal M, Link DC, Dang HX, Larson DE, Kulkarni S, Cordes MG, Fronick CC, Fulton RS, Klco JM, Mardis ER, Ley TJ, Wilson RK, Maher CA Comprehensive discovery of noncoding RNAs in acute myeloid leukemia cell transcriptomes. Exp Hematol 55(None):19-33, 2017. PMID: 28760689.
- Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NL, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN Standards and Guidelines for the interpretation and reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology and College of American Pathologists. The Journal of Molecular Diagnostics 19(1):4-23, 2017. PMID: None.
- Ritter DI, Roychowdhury S, Roy A, Rao S, Landrum MJ, Sonkin D, Shekar M, Davis CF, Hart RK, Micheel C, Weaver M, Van Allen EM, Parsons DW, McLeod HL, Watson MS, Plon SE, Kulkarni S, Madhavan S ClinGen Somatic Cancer Working Group. Somatic cancer variant curation and harmonization through consensus minimum variant level data. Genome Med 8(1):117, 2016. PMID: None.
- Griffith M, Griffith OL, Krysiak K, Skidmore ZL, Christopher MJ, Klco JM, Ramu A, Lamprecht TL, Wagner AL, Campbell KM, Lesurf R, Hundal J, Zhang J, Spies NC, Ainscough BJ, Larson DE, Heath SE, Fronick C, O'Laughlin S, Fulton RS, Magrini V, McGrath S, Smith SM, Miller CA, Maher CA, Payton JE, Walker JR, Eldred JM, Walter MJ, Link DC, Graubert TA, Westervelt P, Kulkarni S, DiPersio JF, Mardis E, Wilson RK, Ley TJ Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-Lymphoblastic leukemia. Exp Hematol 44(7):603-613, 2016. PMID: None.
- Zhang B, Willing M, Grange DK, Shinawi M, Manwaring L, Vineyard M, Kulkarni S, Cottrell CE Multigenerational autosomal dominat inheritance of 5p chromosomal deletions. Am J Med Genet A None(None):None, 2015. PMID: 26601658.
- Griffith M, Miller C, Griffith O, Krysiak K, Skidmore Z, Ramy A, Walker J, Dang H, Trani L, Larson D, Demeter R, Wendle M, McMichael J, Austin R, Magrini V, McGrath S, Ly A, Kulkarni S, Cordes M, Fronick C, Fulton R, Maher C, Ding L, Klco J, Mardis E, Ley T, Wilson R Optimizing Cancer Genome Sequencing and Analysis. Cell Systems 1(3):210-323, 2015. PMID: None.
- Klco J, Miller C, Griffith M, Petti A, Spencer D, Ketkar-Kulkarni S, Wartman L, Christopher M, Lamprecht T, Helton N, Duncavage E, Payton J, Baty J, Heath S, Griffith O, Shen D, Hundal J, Chang G, Fulton R, O'Laughlin, Fronick C, Magrini V, Demeter R, Larson D, Kulkarni S, Ozenberger B, Welch J, Walter M, Graubert T, Westervelt P, Radich J, Link D, Mardis E, DiPersio J, Wilson R, Ley T Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia. JAMA 314(8):811-822, 2015. PMID: 26305651.
- Ungewickell A, Bhanduri A, Rios E, Reuter J, Lee C, Mah A, Zehnder A, Ohgami R, Kulkarni S, Armstrong R, Weng W, Gratzinger D, Tavallaee M, Rook A, Snyder M, Kim Y, Khavari P Genomic analysis of mycosis fungoides and Sezary syndrome identifies recurrent alterations in TNFR2. Nature Genetics None(None):None, 2015. PMID: 26258847.
- Yarbrough CK, Bandt SK, Hurth K, Wambach JA, Rao R, Kulkarni S, White FV, Frater JL, Leonard JR Congenital Acute Myeloid Leukemia with Unique Translocation t(11;19)(q23:p12.3). Cureus None(None):None, 2015. PMID: None.
- Gargis AS, Kalman L, Bick DP, Da Silva C, Dimmock DP, Funke BH, Gowrisankar S, Hedge MR, Kulkarni S, Mason CE, Nagarajan R, Voelkerding KV, Worthey EA, Aziz N, Barnes J, Bennett SF, Bisht H, Church DM, Dimitrova Z, Gargis SR, Hafez N, Hambuch T, Hyland FC, Luna RA, MacCannell D, Mann T, McCluskey MR, McDaniel TK, Ganova-Raeva LM, Rehm HL, Reid J, Campo DS, Resnick RB, Ridge PG, Salit ML, Skums P, Wond LJ, Zehnbauer BA, Zook JM, Lubin IM Good laboratory practice for clinical next-generation sequencing informatics pipelines. Nat Biotechnol 33(7):689-693, 2015. PMID: 26154004.
- Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, Ledbetter DH, Maglott DR, Martin CL, Nussbaum RL, Plon SE, Ramos EM, Sherry ST, Watson MS, Kulkarni S Clingen--the Clinical Genome Resource. N Engl J Med 372(23):2235-2242, 2015. PMID: 26014595.
- Wu N, Ming X, Xiao J, Wu Z, Chen X, Shinawi M, Shen Y, Yu G, Liu J, Xie H, Gucev ZS, Liu S, Yang N, Al-Kateb H, Chen J, Zhang J, Hauser N, Tasic V, Liu P, Su X, Pan X, Liu C, Wang L, Shen J, Shen J, Chen Y, Zhang T, Zhang J, Choy KW, Wang J, Wang Q, Li S, Zhou W, Guo J, Wang Y, Zhang C, Zhao H, An Y, Zhao Y, Wang J, Liu Z, Zuo Y, Tian Y, Weng X, Sutton VR, Wang H, Ming Y, Kulkarni S, Zhong TP, Giampietro PF, Dunwoodie SL, Cheung SW, Zhang X, Jin L, Lupski JR, Qui G, Zhang F TBX6 null variants and a common hypomorphic allele in congenital scoliosis. N Engl J Med 372(4):341-350, 2015. PMID: 25564734.
- Perrino CM, Hucthagowder V, Evenson M, Kulkarni S, Humphrey PA Genetic alterations in renal cell carcinoma with rhabdoid differentiation. Hum Pathol 46(1):9-16, 2015. PMID: 25439741.
- Lincoln S, Funke B, Zook J, Kulkarni S, Browser M, Watson D, Aradhya S, Yang S, Monzon F, Rehm H To Confirm or Not Confirm, That is the Question: A Rigorous Approach to Evaluating the Importance of Sanger Confirmation of NGS Findings. None None(None):753, 2015. PMID: None.
- Lyon E, Cockerill FR 3rd, Bale SJ, Beadling C, Bry L, Hagenkord J, Kulkarni S, Press R, Palomaki GE Next generation sequencing in clinical diagnostics: experiences of early adopters. Clin Chem None(None):None, 2014. PMID: 25421800.
- Hagemann, IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, Al-Kateb H, Nguyen TT, Duncavage EJ, Cottrell CE, Kulkarni S, Nagarajan R, Seibert K, Baggstrom M, Waqar SN, Pfeifer JD, Morgensztern D, Govindan R Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer None(None):None, 2014. PMID: 25345567.
- Kulkarni S Editors Introduction to the Special Issue. Cancer Genet None(None):None, 2013. PMID: None.
- Cottrell CE, Al-Kateb H, Bredemeyer AJ, Duncavage EJ, Spencer DH, Abel HJ, Lockwood CM, Hagemann IS, O'Guin SM, Burcea LC, Sawyer CS, Oschwald DM, Stratman JL, Sher DA, Johnson MR, Brown TJ, Cliften PF, George B, McIntosh LD, Shrivastava S, Nguyen TT, Payton JE, Watson MA, Crosby SD, Head RD, Mitra RD, Nagarajan R, Kulkarni S, Seibert K, Virgin HW 4th, Milbrandt J, Pfeifer JD Validation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology. J Mol Diagn None(None):None, 2013. PMID: 24211365.
- Euteneuer J, Carvalho C, Kulkarni S, Vineyard M, Mark Grady R, Lupski J, Shinawi M Molecular and phenotypic characterization of atypical Williams-Beuren syndrome. Clin Genet None(None):None, 2013. PMID: 24246242.
- Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. Cancer Genome Atlas Research Network. N Engl J Med 368(22):2059-2074, 2013. PMID: 23634996.
- Tang Z, Berlin D, Toji L, Toruner GA, Beiswanger C, Kulkarni S, Martin CL, Emanuel BS, Christman M, Gerry NP A Dynamic Database of Microarray Characterized Cell Lines with Various Cytogenetic and Genomic Backgrounds. G3: Genes, Genomes, Genetics None(None):None, 2013. PMID: 23665875.
- Perlman SJ, Kulkarni S, Manwaring L, Shinawi M Haploinsufficiency of ZNF238 is associated with corpus callosum abnormalities in 1q44 deletions. Am J Med Genet A 161(4):711-716, 2013. PMID: 23494996.
- Sharma MK, Phillips J, Agarwal S, Wiggins WS, Shrivastava S, Koul SB, Bhattacharjee M, Houchins CD, Kalakota RR, George B, Meyer RR, Spencer DH, Lockwood CM, Nguyen TT, Duncavage EJ, Al-Kateb H, Cottrell CE, Godala S, Lokineni R, Sawant SM, Chatti V, Surampudi S, Sunkishala RR, Darbha R, Macharla S, Milbrandt JD, Virgin HW, Mitra RD, Head RD, Kulkarni S, Bredemeyer A, Pfeifer JD, Seibert K, Nagarajan R Clinical Genomicist Workstation. None None(None):156-157, 2013. PMID: None.
- Al-Kateb H, Shimony JS, Vineyard M, Manwaring L, Kulkarni S, Shinawi M NR2F1haploinsufficiency is associated with optic atrophy, dysmorphism and global developmental delay. Am J Med Genet A 161(2):377-381, 2013. PMID: 19471318.
- Spencer DH, Abel HJ, Lockwood CM, Payton JE, Szankasi P, Kelley TW, Kulkarni S, Pfeifer JD, Duncavage EJ Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next-Generation Sequencing Data. J Mol Diagn 15(1):81-93, 2013. PMID: 23159595.
- Mills KI, Anderson J, Levy PT, Cole FS, Silva JN, Kulkarni S, Shinawi M Duplication of 20p12.3 associated with familial Wolff-Parkinson-White syndrome. Am J Med Genet A 161A(1):137-144, 2012. PMID: 23239491.
- Gargis A, Kalman L, Berry M, Bick D, Dimmock D, Hambuch T, Lu F, Lyon E, Voelkerding K, Zehnbauer B, Agarwala R, Bennett S, Chen B, Chin E, Compton J, Das S, Farkas D, Ferber M, Funke B, Furtado M, Ganova-Raeva L, Geigenmuller, U, Gunselman S, Hegde M, Johnson P, Kasarskis A, Kulkarni S, Lenk T, Liu C, Manion M, Manolio T, Mardis E, Merker J, Rajeevan M, Reese M, Rehm H, Simen B, Yeakley J, Zook J, Lubin I Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 30(11):1033-1036, 2012. PMID: 23138292.
- Welch JS, Ley TJ, Link DC, Miller CA, Larson DE, Koboldt DC, Wartman LD, Lamprecht TL, Liu F, Xia J, Kandoth C, Fulton RS, McLellan MD, Dooling DJ, Wallis JW, Chen K, Harris CC, Schmidt HK, Kalicki-Veizer JM, Lu C, Zhang Q, Lin L, O'Laughlin MD, McMichael JF, Delehaunty KD, Fulton LA, Magrini VJ, McGrath SD, Demeter RT, Vickery TL, Hundal J, Cook LL, Swift GW, Reed JP, Alldredge PA, Wylie TN, Walker JR, Watson MA, Heath SE, Shannon WD, Varghese N, Nagarajan R, Payton JE, Baty JD, Kulkarni S, Klco JM, Tomasson MH, Westervelt P, Walter MJ, Graubert TA, DiPersio JF, Ding L, Mardis ER, Wilson RK The origin and evolution of mutations in acute myeloid leukemia. None 150(2):264-278, 2012. PMID: 22817890.
- Uy GL, Rettig MP, Motabi IH, McFarland K, Trinkaus KM, Hladnik LM, Kulkarni S, Abboud CN, Cashen AF, Stockerl-Goldstein K, Vij R, Westervelt P, DiPersio JF A phase I/II study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia. Blood 119(17):3917-3924, 2012. PMID: 22308295.
- Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DA, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, McMichael JF, Wallis JW, Lu C, Shen D, Harris CC, Dooling DJ, Fulton RS, Fulton LL, Chen K, Schmidt H, Kalicki-Veizer J, Magrini VJ, Cook L, McGrath SD, Vickery TL, Wendl MC, Heath S, Watson MA, Link DC, Tomasson MH, Shannon WD, Payton JE, Kulkarni S, Westervelt P, Walter MJ, Graubert TA, Mardis ER, Wilson RK, DiPersio JF Clonal evolution in relapsed acute myeloid leukemia revealed by whole-genome sequencing. Nature 481(7382):506-510, 2012. PMID: 22237025.
- Stankiewicz P, Kulkarni S, Dharmadhikari AV, Sampath S, Bhatt SS, Shaikh T, Xia Z, Pursley AN, Cooper LM, Shinawi M, Paciorkowski A, Grange DK, Noetzel M, Saunders S, Simons P, Summar M, Lee B, Scaglia F, Fellmann F, Martinet D, Beckmann JS, Asamoah A, Platky K, Sparks S, Martin AS, Madan-Khetarpal S, Hoover J, Medne L, Bonnemann CG, Moeschler JB, Vallee SE, Parikh S, Irwin P, Dalzell VP, Smith WE, Banks VC, Flannery DB, Lovell CM, Bellus GA, Golden-Grant K, Gorski J, Kussmann JL, McGregor TL, Hamid R, Pfotenhauer J, Ballif BC, Shaw CA, Kang S, Bacino CA, Patel A, Rosenfeld JA, Cheung S, Shaffer LG Recurrent deletions and reciprocal duplications of 10q11.21q11.23 including CHAT and SLC18A3 are likely mediated by complex low-copy repeats. Human Mutation 33(None):165-179, 2012. PMID: 21948486.
- Paciorkowski, AR, Thio, LL, Rosenfeld, JA, Gajecka, M, Gurnett, CA, Kulkarni, S, Chung, WK, Marsh, ED, Gentile, M, Reggin, JD, Wheless, JW, Balasubramanian, S, Kumar, R, Christian, SL, Marini, C, Guerrini, R, Maltsev, N, Shaffer, LG, Dobyns, WB Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic function. Eur J Hum Genet 19(12):1238-1245, 2011. PMID: 21694734.
- Kreisel, F, Kulkarni, S, Kerns, RT, Hassan, A, Deshmukh, H, Nagarajan, R, Frater, JL, Cashen, A High-resolution copy number alterations in diffuse large B-cell lymphoma that predict response to 10mmune-chemotherapy. Journal of Molecular Diagnostics 204(3):129-137, 2011. PMID: 21504712.
- Welch, JS, Westervelt, P, Ding, L, Larson, DE, Klco, JM, Kulkarni, S, Wallis, J, Chen, K, Payton, JE, Fulton, RS, Veizer, J, Schmidt, H, Vickery, TL, Heath, S, Watson, MA, Tomasson, MH, Link, DC, Graubert, TA, DiPersio, JF, Mardis, ER, Ley, TJ, Wilson, RK Use of whole genome sequencing to diagnose a cryptic fusion oncogene. JAMA 305(15):1577-1584, 2011. PMID: 21505136.
- Link, DC, Schuettpelz, LG, Shen, D, Wang, J, Walter, MJ, Kulkarni, S, Payton, JE, Ivanovich, J, Goodfellow, PJ, Le Beau, M, Koboldt, DC, Dooling, DJ, Fulton, RS, Bender, HF, Fulton, LL, Delehaunty, KD, Fronick, CC, Appelbaum, EL, Schmidt, H, Maupin, R, O'Laughlin, M, Chen, K, McLellan, MD, Varghese, N, Nagarajan, R, Graubert, TA, Ding, L, Ley, TJ, Zambetti, GP, Wilson, RK, Mardis, ER The identification of a novel TP53 germline mutation through whole genome sequencing of a patient with therapy-related AML. JAMA 305(15):1568-1576, 2011. PMID: 21505135.
- Klco, JM, Kulkarni, S, Kreisel, FH, Nguyen, TDT, Hassan, A, Frater, JL Immunohistochemical Analysis of Monocyctic Leukemias: Usefulness of CD14 and Kruppel-like Factor 4, a Novel Monocyte Marker. American Journal of Clinical Pathology 135(5):720-730, 2011. PMID: 21502426.
- Martin, MG, Welch, J, UY, GL, Fehniger, TA, Kulkarni, S, Duncavage, EJ, Walter, MJ Limited engraftment of low-risk myelodyplastic syndrome cells in NOD/SCID gamma-C chain knockout mice. Leukemia 24(None):1662-1664, 2010. PMID: 20668474.
- McDonald, S, Wilson, DB, Pumbo, E, Kulkarni, S, Mason, PJ, Else, T, Bessler, M, Ferko, IT, Shenoy, S Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features of dyskeratosis 10mmune10tal and IMAGe association. Pediatr Blood Cancer 54(1):154-157, 2010. PMID: 19760774.
- Zhang, B, Chang, B, Fu, M, Huang, J, Kashyap, R, Salavaggione, E, Jain, S, Kulkarni, S, Deardorff, MA, Uzielli, MLG, Dorsett, D, Beebe, DC, Jay, PY, Heuckeroth, RO, Krantz, I, Milbrandt, J Dosage Effects of Cohesin Regulatory Factor PDS5 on Mammalian Development: Implications for Cohesinopathies. PLoS One 4(5):e5232, 2009. PMID: 19412548.
- Hulick, PJ, Noonan, KM, Kulkarni, S, Donovan, DJ, Listewnik, M, Ihm, C, Stoler, JM, Weremowicz, S Cytogenetic and array-CGH characterization of a complex de novo rearrangement involving duplication and deletion of 9p and clinical findings in a 4-month-old female. Cytogenet Genome Res 126(3):305-312, 2009. PMID: 20068300.
- Kulkarni S, Baron, JM, Mahowald, MA, Moon, C, Bassing, CH, Kulkarni S, Bredemeyer, A, Sleckman, BP Breakpoint target restrictions for aberrantly resolved DNA double stranded breaks in ATM-deficient lymphocytes. Proc Natl Acad Sci U S A 106(43):18339-18344, 2009. PMID: 19820166.
- Hamvas, A, Nogee, LM, Wegner, DJ, DePass,K, Christodoulou, J, Bennetts, B, McQuade, LR, Gray, PH, Deterding, RR, Carroll, TR, Kammesheidt, A, Kasch, LM, Kulkarni, S, Cole, FS Inherited surfactant deficiency due to uniparental disomy of rare mutations in the surfactant protein-B and ATP biding cassette, subfamily A, member 3 genes. J Pediatr 155(6):854-859.e1, 2009. PMID: 19647838.
- Higgins, AW, Alkuraya, FS, Bosco, AF, Brown, KK, Bruns, GA, Donovan, DJ, Eisenman, R, Fan, Y, Farra, CG, Ferguson, HL, Gusella, JF, Harris, DJ, Herrick SR, Kelly, C, Kim, HG, Kishikawa, S, Korf, BR, Kulkarni, S, Lally, E, Leach, NT, Lemyre, E, Lewis, J, Ligon, AH, Lu, W, Maas, RL, MacDonald, ME, Moore, SD, Peters, RE, Quade, BJ, Quintero-Rivera, F, Saadi, I, Shen, Y, Shendure, J, Williamson, RE, Morton. CC Characterization of Apparently Balanced Chromosomal Rearrangements from the Development Genome Anatomy Project. Am J of Hum Genet 82(None):712-722, 2008. PMID: 18319076.
- Saharia, A, Guittat, L, Crocker, S, Kulkarni S, Steffen, M, Stewart, S Flap Endonuclease-1 Contributes To Telomere Stability. Current Biology 18(None):496-500, 2008. PMID: 18394896.
- Klco, JM, Kreisel, FH, Zehnbauer, BA, Kulkarni S, Hassan, A, Frater, JL The spectrum of adult B-Lymphoid Leukemias with BCR-ABL; molecular diagnostic, cytogenetic, and clinical laboratory perspectives. Am J Hematol 83(12):901-907, 2008. PMID: 18932238.
- Kulkarni, S, Nagarajan, P, Wall, J, Donovan, D, Donell, RL, Ligon, AH, Venkatachalam, S, Quade, BJ Disruption of Chromodomain Helicase DNA Binding Protein 2 (CHD2) Causes Scoliosis. Am J Med Genet 146A(9):1117-1127, 2008. PMID: 18386809.
- Lu, W, van Eerde, AM, Fan, X, Quintero-Rivera, F, Kulkarni, S, Ferguson, H, Kim, H, Sanlaville, D, Andrews, W, Sundaresan, V, Bi, W, Yan, J, Giltay, JC, Wijmenga, C, de Jong, TP, Feather, S, Woolf, AS, Rao, Y, Lupski, J, Quade, BJ, Gusella, JF, Morton, CC, Maas, R Disruption of ROBO2 is associated with congenital anomalies of the kidney and urinary tract and confers risk of vesicoureteral reflux. Am J Hum Genet 80(4):616-6312, 2007. PMID: 17357069.
- Knudson, M, Kulkarni, S, Ballas, K, Bessler, M, Goldman, F Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis 9mmune9tal. Blood 105(None):682-688, 2005. PMID: 15238429.
- Goldman, F, Bouharich, R, Kulkarni, S, Freeman, S, Du, HY, Harrington, L, Mason, PJ, Londono-Vallejo, A, Bessler, M The effect of TERC haploinsufficiency on the inheritance of telomere length. Proc Natl Acad Sci U S A 102(47):17119-17124, 2005. PMID: 16284252.
- Mochizuki, Y, He, J, Kulkarni S, Bessler, M, Mason, PJ Mouse dyskerin mutations affecting mTERC levels, telomerase activity and ribosomal RNA processing. Proc Natl Acad Sci U S A 101(29):10756-10761, 2004. PMID: 15240872.
- Kulkarni S, Bessler, M Effect of proinflammatory cytokines on PIGA-hematopoiesis. Experimental Hematology 31(9):770-778, 2003. PMID: 12962722.
- Kulkarni, S, Bessler, M The effect of GPI-linked deficiency on apoptosis in mice carrying a Piga gena in hematopoietic cells. Journal of Leukocyte Biology 72(6):1228-1233, 2002. PMID: 12488505.
- Kulkarni, S, Heath, C, Parker, S, Chase, A, Iqbal, S, Pocock, CF, Kaeda, J, Cwynarski, K, Goldman, JM, Cross, NC Fushion of H4/D10S170 to the platelet-derived growth factor receptor beta (PDGFR ß) in BCR-ABL-negative myeloproliferative disorders with a t(5;10) (q33;q21). Cancer Res 60(13):3592-3598, 2000. PMID: 10910073.
- Kulkarni S, Reiter, A, Smedley, D, Goldman, JM, Cross, NCP The complete genomic structure of ZNF198 and the 8mmune8tal8n of breakpoints in t(8;13) myeloproliferative disorders. Genomics 55(None):118-121, 1999. PMID: 9889006.
- How, GF, Kulkarni, S, Tan, LT, Cross, NCP Two patients with novel BCR/ABL fusion transcripts (e8/a2 and e13a2) resulting from translocation breakpoints within BCR exons. British Journal of Haematology 105(None):434-436, 1999. PMID: 10233416.
- Kulkarni S, Grand, F, Chase, A, Goldman, JM, Gordon, M, Cross, NCP Frequent deletion of hSNF5/INI-1, a component of SWI/SNF Complex, in chronic myeloid leukemia. Cancer Res 59(None):3870-3874, 1999. PMID: 10463572.
- Kulkarni S, Ammini AC, Kucheria K Marker chromosome in a Turner patient. Indian J Hum Genet 1(2):123-126, 1995. PMID: None.
- Ramos E, Bien-Willner G, Li J, Hughes A, Giacalone J, Chasnoff S, Kulkarni S, Parmacek M, Cole F, Druley T Genetic variation in MKL2 and decreased downstream PCTAIRE1 expression in extreme, fatal primary human microcephaly. Clin Genet None(None):None. PMID: 23692340.
Abstracts
- J Chu, R Schell, F Wu, M Krawczyk, D Whang, S Jung, H Nam, KB Thomas, FJ Lopez-Diaz, V Funari, JA Mayer, S Kulkarni, J Guo, SP Lau-Rivera. A single stranded DNA library preparation workflow used for hybridization capture-based WES assay showed superior uniformity. In: Proceedings of the 115th Annual Meeting of the American Association for Cancer Research. None None(None):None. e-Pub 2024. PMID: None.
- Magnan CN, Nam H, Kulkarni S, Jung SC. Bridging the gap between targeted NGS and FISH gene-level CNV detection capabilities in hematologic malignancies. Cancel Research 83(None):4294. e-Pub 2023. PMID: None.
- Lin WH, Roy A, Church A, Rao S, Ritter D, Danos A, Kulkarni S, Madhavan S, Xu X, Kanagal-Shamana R, Dyer L, Harris M, Akkari Y, Paz-Yaacov N, Terraf P, Raca G. Curation of genetic variants in childhood cancers within the Clinical Genome Resource (ClinGen). Cancer Genetics 244(None):11-12, 2020. PMID: None.
- Church AJ, Rao S, Ritter D, Griffith M, Griffith OL, Kulkarni S, Madhavan S, Roy A, Raca G. Curation of Pediatric cancer variants within the Clinical Genome Resource (ClinGen). None None(None):None, 2019. PMID: None.
- Rosenbaum JN, Branson J, Cottrell C E, Pfeifer JD, Kulkarni S, Duncavage EJ. Next Generation Sequencing Reveals Genomic Heterogenity of ALK Fushion Breakpoints in Non-Small Cell Lung Cancer. Laboratory Investigation 96(None):481A-482A, 2016. PMID: None.
- Reiter, A, Kulkarni, S, Chase, A, Macdonald, DHC, Aguiar, RCT, Goncalves, C, Hernandez, JM, Jennings, BA, Goldman, JM, Cross, NCP. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13) (p11;q12) myeloproliferative syndrome. Blood 92(5):1735-1742, 1998. PMID: 9716603.
- Schell R, Lau-Rivera S, Chu J, Wu F, Krawczyk M, Lopez-Diaz, Kulkarni S. A Novel Lab-Developed Test Simultaneously Assays Heme and Solid Tumors and Shows Good Performance on Degraded Samples at Low Minimum Input. Journal of Molecular Diagnostics 25(11):S120-S120. PMID: None.
- Krawczyk M, Duong C, Zelinger L, Ye F, Nam H, Thomas B, Funari V, Kulkarni S, Lopez-Diaz. Landscape of known and novel myeloid neoplasia fusions identified by a multimodal comprehensive genomic profiling test in 789 patients. Cancer Research 83(None):1401. PMID: None.
- Zelinger L, Koo S, Ko C, Alarcon F, Thomas KB, Jung SC, Diaz FJL, Ye F, Kulkarni S. Single-tube NGS profiling allows identification of molecular signature in ALL patients. Cancer Res 83(None):219. PMID: None.
Book Chapters
- Kulkarni S, Pfeiffer J. Emerging DNA Sequencing Technologies. In: Clinical Genomics: A Guide to Clinical Next Generation Sequencing. None. Elsevier Science, None, 2014.
- Kulkarni S, Pfeifer J. Clinical Genomics: A Guide to Clinical Next Generation Sequencing. In: Clinical Genomics: A Guide to Clinical Next Generation Sequencing. None. Elsevier Science, None, 2014.
- Kulkarni S, Ketkar S. RNA-Sequencing and Methylome Analysis. In: Clinical Genomics: A Guide to Clinical Next Generation Sequencing. None. Elsevier Science, None, 2014.
- Kulkarni S. Clinical Cytogenomics and Molecular Pathology. In: The Washington Manual of Surgical Pathology. None. Lippincott Williams and Wilkins, None, 2011.
- Kulkarni S, Pfeiffer J. Cytogenetics. In: The Washington Manual of Surgical Pathology. None. Lippincott Williams and Wilkins, None, 2008.
- Bessler M, Kulkarni S, Jasinski M, Schaefer A, Keller P, Tremml G. Mice with blood cells deficient in GPI-linked proteins-The generation of murine model to investigate the pathogenesis and pathophysiology of Paroxysmal Nocturnal Hemoglobinuria (PNH) Chapter 2 in Pa. In: (Chapter 2) Paroxysmal Nocturnal Hemoglobinuria (PNH) and related Disorders; Molecular Aspects of Pathogenesis. None. Springer Verlag Publications, 27-41, 2003.
Selected Presentations & Talks
Local Presentations
- 2017. Molecular and Human Genetics. Invited. Houston, Texas, US.
- 2017. Head Neck Cancer Genomics seminar series. Invited. Houston, Texas, US.
- 2017. N/A. Invited. Grand Rounds. Houston, Texas, US.
National Presentations
- 2024. Current state of Molecular Pathology-The future is here. Invited. Grand Rounds. Rochester, MN, US.
- 2023. Key learnings from executing integrated diagnostic strategies in large reference laboratories. Invited, US.
- 2021. Medical Genome Initiative: Multi-Institutional efforts to create and implement best practice guidelines for utility of whole-genome sequencing for improving diagnostic yield in germline genetic disorders. Invited. Genomics in Health Implementation Forum (GHIF), US.
- 2021. Moving Whole-Genome Sequencing for Rate Diagnosis to the Clinic. Panelist. Global Alliance for Genomic Health (GA4GH), US.
- 2019. N/A. Invited. CommonSpirit Health Precision Medicine Retreat. Denver, CO, US.
- 2019. N/A. Invited. Association of Molecular Pathology, 2019 Annual meeting and exp. Baltimore, MD, US.
- 2019. N/A. Invited. Scientific Advisory Board. Anaheim, CA, US.
- 2019. N/A. Invited. Bremerton, WA, US.
- 2019. N/A. Invited. Colorado Springs, CO, US.
- 2018. N/A. Invited. Seminar at Molecular Tumor Board meeting. Dallas, TX, US.
- 2018. Weighing the Evidence: Variant Classification & Interpretation in Precision Oncology. Panelist. Grand Rounds. Silver Springs, MD, US.
- 2017. N/A. Invited. Grand Rounds Seminar. New York, NY, US.
- 2017. Curating the Clinical Genome. Invited. Curating the Clinical Genome 2017 meeting. Washington, D.C, US.
- 2017. N/A. Visiting. Memphis, TN, US.
- 2017. Omics. Invited. Omics Workshop, TX, US.
- 2016. N/A. Panelist. FDA workshop on Next Generation Sequencing-based oncology panels. Silver Springs, MD, US.
- 2016. Geisinger Autism and Developmental Medicine. Invited. Grand Rounds, US.
- 2015. A Clinical Perspective, Cancer Genomics Program. Invited. Second Annual Applied Cancer Genomics: A Clinical Perspective, Cancer Genomics Program. Toronto, CA, US.
- 2015. N/A. Invited. Grand Rounds. Boston, MA, US.
- 2015. A Blueprint for Drug/Diagnostic Co-Development: Genetic Databases. Panelist. Washington, D.C, US.
- 2015. Cancer Somatic ClinGen efforts. Invited. Sixth Annual Cancer Genomics Consortium meeting. Denver, CO, US.
- 2015. N/A. Invited. Grand Rounds. Houston, TX, US.
- 2015. The Utility of Next-Generation Sequencing Assays Across the Continuum of Clinical Care (short course). Invited. American College of Medical Genetics and Genomics Annual Meeting, US.
- 2015. Advances in Understanding Cancer Genomes through Clinical Next-Generation Sequencing. Invited. Understanding your Genome meeting. San Francisco, CA, US.
- 2014. N/A. Visiting. Grenada, WI, US.
- 2014. Genomics, Precision Medicine & Cancer, Advances in Diagnosis and Treatment of Hematologic Malignancies. Invited. CME Seminar. St Louis, MO, US.
- 2014. Return of incidental findings in cancer in the genomic era. Invited. International collaboration for Clinical Genomics conference. Bethesda, MD, US.
- 2014. Pathology Research Seminar Series. Invited. Charlottesville, VA, US.
- 2014. N/A. Panelist. Washington, D.C, US.
- 2014. N/A. Visiting. Tucson, AZ, US.
- 2013. N/A. Invited. Grand Rounds. Atlanta, GA, US.
- 2013. N/A. Visiting. Grenada, WI, US.
- 2013. Cancer Cytogenomics. Invited. Cancer Cytogenomics Consortium. Chicago, IL, US.
- 2013. N/A. Invited. P13K Pathologist Advisory Board Meeting. Novartis, New Jersey, US.
- 2013. N/A. Invited. Bethesda, MD, US.
- 2013. N/A. Invited. Think Tank Summit. Chicago, IL, US.
- 2013. N/A. Invited. Cambridge/Boston, MA, US.
- 2013. N/A. Invited. Boston, MA, US.
- 2013. Molecular Pathology NGS CPT (Current Procedural Terminology) Editorial Panel. Invited. Chicago, IL, US.
- 2013. N/A. Invited. Washington, D.C, US.
- 2013. N/A. Invited. Grand Rounds. Rochester, NY, US.
- 2013. Molecular Medicine. Invited. Molecular Medicine, Tri-Con. San Francisco, CA, US.
- 2012. N/A. Invited. American Molecular Pathology (AMP) Annual Meeting. Long Beach, CA, US.
- 2012. N/A. Invited. Omics Evolution Summit. Boston, MA, US.
- 2012. N/A. Invited. 2012 ISCA Consortium Conference. Bethesda, MD, US.
- 2012. Next-Generation DNA Sequencing as a Tool for Clinical Decision-making in Cancer Patient Management. Invited. Next-Generation DNA Sequencing as a Tool for Clinical Decision-making in Cancer Patient Management Workshop. Bethesda, MD, US.
- 2012. CMA Short Course. Invited. Annual Clinical Genetics Meeting. Charlotte, NC, US.
- 2012. N/A. Invited. Grand Rounds. Minneapolis, MN, US.
- 2012. Molecular Med Tri-Con. Invited. San Francisco, CA, US.
- 2011. Illumina Next-Generation sequencing workshop. Invited. American Molecular Pathology (AMP) meeting. Dallas, TX, US.
- 2011. Genetic Testing Reference Material. Invited. 7th Genetic Testing Reference Material Program at CDC (GeTRM) Expert panel meeting; ; American Molecular Pathology (AMP) meeting. Dallas, TX, US.
- 2011. Affymetrix Cytogenomics. Invited. Affymetrix Cytogenomics symposia at the International Congress of Human Genetics, US.
- 2011. Pathology. Visiting. Pathology Grand Rounds, Florida, US.
- 2011. Innovations in Molecular, Cytogenetic and flow cytometry technologies. Invited. International Society of Laboratory Hematology. New Orleans, LA, US.
- 2011. National Workgroup of Implementation of Next Generation Sequencing into Clinical Practice. Panelist. Atlanta, GA, US.
- 2011. Clinical Laboratory Improvement. Panelist. Atlanta, GA, US.
- 2011. Cytogenomic Arrays. Invited. First Annual ISCA Consortium (The International Standards for Cytogenomic Arrays Consortium) Conference. Atlanta, GA, US.
- 2010. Genetic Testing Reference Material. Invited. The 6th Annual Genetic Testing Reference Material Program at CDC (GeT-RM) Meeting. San Jose, CA, US.
- 2010. Affymetrix seminar. Invited. American Society of Human Genetics Meeting 2010. Washington, D.C, US.
- 2010. Multi-Institutional Collaborative Effort for Establishing Reference Material for Chromosomal Microarrays. Invited. Cytogenomics User Group meeting. Chicago, IL, US.
- 2010. Novartis Oncology Preceptorship. Invited. Eric P Newman Center, US.
- 2009. Novartis Oncology Preceptorship. Invited. Eric P Newman Center, US.
- 2009. Medical Genomics. Invited. Eric P Newman Center, US.
- 2009. N/A. Invited, US.
- 2008. Novartis Oncology Preceptorship. Invited. Division of Oncology, US.
- 2007. Medical Genetics Lecture Series, Central Institute of Deaf. Invited, US.
- 2007. Midwest Pediatric Endocrinology Society Meeting. Invited. Chicago, US.
- Iron Overload. Invited. Iron Overload Seminar. St Louis, MO, US.
International Presentations
- 2019. N/A. Invited. Australia's Biotechnology Organization meeting. Melbourne, AU.
- 2019. N/A. Invited. International Society of Reproductive Genetics. Beijing, CN.
- 2018. N/A. Invited. Baylor College of Medicine and Fudan University joint research meeting, HK.
- 2018. N/A. Invited. 2nd BCM-CUHK-Fudan Joint Symposium in Clinical Genetics and Birth Defects cum 14th Asia Pacific Congress in Maternal Fetal Medicine, HK.
- 2018. Clinical Cancer Genomics and Personalized Medicine. Invited. First joint US-Japan Clinical Cancer Genomics and Personalized Medicine symposium. Tokyo, JP.
- 2017. N/A. Invited. Grand Rounds. Nagoya, JP.
- 2017. N/A. Invited. Specialty Reference Laboratories (SRL). Tokyo, JP.
- 2012. Clinical Genetics. Invited. Slovak Society of Medical Genetics, Slovak Medical Association, St. Elizabeth Cancer Institute 23rd Izakovic Memorial. Bratislava, SK.
- 2012. Molecular Pathology of Solid Tumors: Cancer Profiling for Targeted Treatment Prediction. Invited, SE.
- 2009. The AMP-AACC Molecular Pathology Essentials review course. Invited. Copenhagen, DK.
- 2009. Cytogenetics. Invited. Seventh European Cytogenetics Conference, Stockholm, Sweden, SE.
Patient Reviews
CV information above last modified February 10, 2025